Evidence map›Paper›PMID 35741015›Full record

ReviewCells2022

Céline Sélénou, Frédéric Brioude, Eloïse Giabicani, Marie-Laure Sobrier, Irène Netchine

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
18.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. H19 and IGF2 imprinting from embryogenesis to oncogenesis.Frontiers in cell and developmental biology · 2026
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Céline SélénouCentre de Recherche Saint-Antoine, INSERM, Sorbonne Université, F-75012 Paris, France.
Frédéric BrioudeCentre de Recherche Saint-Antoine, INSERM, Sorbonne Université, F-75012 Paris, France.ORCID 0000-0001-8122-760X
Eloïse GiabicaniCentre de Recherche Saint-Antoine, INSERM, Sorbonne Université, F-75012 Paris, France.
Marie-Laure SobrierCentre de Recherche Saint-Antoine, INSERM, Sorbonne Université, F-75012 Paris, France.
Irène NetchineCentre de Recherche Saint-Antoine, INSERM, Sorbonne Université, F-75012 Paris, France.
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the 30 years since the first report of parental imprinting in insulin-like growth factor 2 (

Indexed as

Beckwith-Wiedemann SyndromeSilver-Russell SyndromeAnimalsEpigenomicsGenomic ImprintingHumansInsulin-Like Growth Factor IIMiceIGF2 protein, humanInsulin-Like Growth Factor IIBeckwith–Wiedemann syndromegrowthIGF2parental imprintingSilver–Russell syndrome

Identifiers

PMID35741015
PMCPMC9221339
OpenAlexW4281641698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.